SIGA Q3 revenue falls to $1.3 million; net loss narrows to $2.9 million
SIGA Technologies reported third-quarter 2026 total revenues of $1.3 million, down from $2.6 million a year earlier, and a net loss of $2.9 million, or $0.04 per diluted share, compared with a net loss of $6.4 million, or $0.09 per share, in the same quarter of 2025. For the nine months ended September 30, 2026, total revenues were $48.6 million versus $90.8 million a year earlier, and net income was $6.1 million, or $0.09 per diluted share, versus $28.7 million, or $0.40 per share.
Key points
- Q3 2026 total revenues were $1.3 million versus $2.6 million in Q3 2025; operating loss was $6.5 million versus $10.2 million.
- Nine-month 2026 total revenues were $48.6 million versus $90.8 million; net income was $6.1 million versus $28.7 million.
- In October 2026, the Canadian Department of National Defence awarded SIGA a contract for up to approximately $15 million of oral TPOXX through March 31, 2031.
- Dennis Hrubry, Executive Vice President and Chief Scientific Officer, retired effective November 9, 2026, and will continue in an advisory role; cash and cash equivalents were $116.4 million at September 30, 2026, versus $155.0 million at D
The filing
Written by AI on Nov 9, 2026, 6:16 PM ET, from this filing only.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.